Year archive

Jiangsu Recbio Technology Co., Ltd. — 2022 filings

All 81 regulatory filings released by Jiangsu Recbio Technology Co., Ltd. (2179) in 2022, sourced directly from the official regulator.

81 Filings

2022 Period

2022 filings (81)

Filing	Released	Lang
TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD Remuneration Information	2022-12-28	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING, CLASS MEETING FOR HOLDERS OF DOMESTIC SHARES AND UNLISTED FOREIGN SHARES AND H SHARE CLASS MEETING HELD ON DECEMBER 28, 2022 Declaration of Voting Results & Voting Rights Announcements	2022-12-28	English
VOLUNTARY ANNOUNCEMENT SUPERIOR NEUTRALIZING ANTIBODY TITER LEVELS AGAINST OMICRON BF.7 AND BA.2.75 OF THE COMPANY'S TWO-COMPONENT RECOMBINANT COVID-19 VACCINE RECOV AS COMPARED TO INTERNATIONAL Regulatory Filings	2022-12-23	English
VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL APPROVAL FOR THE COMPANY'S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN THE PHILIPPINES Regulatory Filings	2022-12-19	English
VOLUNTARY ANNOUNCEMENT SUPERIOR RESULTS OF THE COMPARATIVE STUDY OF THE COMPANY'S RECOMBINANT TWO-COMPONENT COVID-19 VACCINE ReCOV AS COMPARED TO INTERNATIONAL MAINSTREAM mRNA VACCINE Regulatory Filings	2022-12-14	English
Form of Proxy for use at the 2022 Second H Share Class Meeting to be held on Wednesday, December 28, 2022 Proxy Solicitation & Information Statement	2022-12-12	English
Form of Proxy for use at the 2022 Third Extraordinary General Meeting to be held on Wednesday, December 28, 2022 Proxy Solicitation & Information Statement	2022-12-12	English
NOTICE OF H SHARE CLASS MEETING Proxy Solicitation & Information Statement	2022-12-12	English
NOTICE OF EXTRAORDINARY GENERAL MEETING AGM Information	2022-12-12	English
PROPOSED ISSUANCE OF DOMESTIC SHARES, PROPOSED AUTHORIZATION TO THE BOARD AND ITS DELEGATED PERSONS TO DEAL WITH MATTERS RELATING TO THE ISSUANCE OF DOMESTIC SHARES, NOTICE OF THE EXTRAORDINARY GENERA Proxy Solicitation & Information Statement	2022-12-12	English
CLOSURE OF REGISTER OF MEMBERS Regulatory Filings	2022-12-07	English
INSIDE INFORMATION ANNOUNCEMENT LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE FOR THE H SHARE FULL CIRCULATION Share Issue/Capital Change	2022-12-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 Regulatory Filings	2022-12-01	English
VOLUNTARY ANNOUNCEMENT THE COMPANY'S FIRST PHASE OF MANUFACTURING FACILITY WITH A MAXIMUM ANNUAL OUTPUT OF 20 MILLION DOSES OF RECOMBINANT HPV 9-VALENT VACCINE Capital/Financing Update	2022-11-21	English
INSIDE INFORMATION ANNOUNCEMENT APPROVAL BY THE CSRC OF H SHARE FULL CIRCULATION APPLICATION OF THE COMPANY Regulatory Filings	2022-11-10	English
VOLUNTARY ANNOUNCEMENT COMPLETION THE FIRST BATCH OF SUBJECT ENROLLMENT FOR THE INTERNATIONAL MULTI-CENTER PHASE III CLINICAL TRIAL OF RECOMBINANT COVID-19 VACCINE ReCOV Regulatory Filings	2022-11-08	English
VOLUNTARY ANNOUNCEMENT POSITIVE RESULTS OF MULTIPLE OVERSEAS PHASE II CLINICAL TRIALS OF RECOMBINANT COVID-19 VACCINE ReCOV Regulatory Filings	2022-11-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 Regulatory Filings	2022-11-01	English
(1) PROPOSED ISSUANCE OF DOMESTIC SHARES (2) PROPOSED AUTHORIZATION TO THE BOARD AND ITS DELEGATED PERSONS TO DEAL WITH MATTERS RELATING TO THE ISSUANCE OF DOMESTIC SHARES (3) PROPOSED CHANGE OF REGIS Capital/Financing Update	2022-10-31	English
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF THE APPLICATION FOR CLINICAL TRIAL OF NOVEL ADJUVANTED RECOMBINANT QUADRIVALENT HPV VACCINE Regulatory Filings	2022-10-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 Regulatory Filings	2022-10-03	English
2022 Interim Report Interim / Quarterly Report	2022-09-26	English
ARTICLES OF ASSOCIATION Governance Information	2022-09-16	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 16, 2022 AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RESIGNATION OF THE SUPERVISOR AND RE-ELECTION OF THE CHAIRPERSON OF THE SUPER Declaration of Voting Results & Voting Rights Announcements	2022-09-16	English
DISCLOSEABLE TRANSACTIONS SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS Capital/Financing Update	2022-09-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 Regulatory Filings	2022-09-01	English
Form of Proxy for use at the 2022 Second Extraordinary General Meeting to be held on Friday, September 16, 2022 Proxy Solicitation & Information Statement	2022-08-31	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2022-08-31	English
2022 H SHARE INCENTIVE SCHEME AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS AND ITS DELEGATES TO DEAL WITH MATTERS RELATED TO THE 2022 H SHARE INCENTIVE SCHEME AMENDMENTS TO THE ARTICLES OF ASSOCIAT Proxy Solicitation & Information Statement	2022-08-31	English
UNAUDITED INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022 Interim / Quarterly Report	2022-08-25	English
INSIDE INFORMATION ANNOUNCEMENT ACCEPTANCE BY THE CSRC OF H SHARE FULL CIRCULATION APPLICATION OF THE COMPANY Regulatory Filings	2022-08-25	English
(1) PROPOSED ADOPTION OF 2022 H SHARE INCENTIVE SCHEME (2) PROPOSED AUTHORIZATION GRANTED TO THE BOARD AND ITS DELEGATES TO DEAL WITH MATTERS RELATED TO THE 2022 H SHARE INCENTIVE SCHEME (3) PROPOSED Board/Management Information	2022-08-25	English
VOLUNTARY ANNOUNCEMENT COMPLETION OF SUBJECT ENROLLMENT AND VACCINATION FOR THE COMPARATIVE STUDY BETWEEN ReCOV AND mRNA VACCINES Regulatory Filings	2022-08-19	English
ARTICLES OF ASSOCIATION Governance Information	2022-08-15	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING, CLASS MEETING FOR HOLDERS OF DOMESTIC SHARES AND UNLISTED FOREIGN SHARES AND H SHARE CLASS MEETING HELD ON AUGUST 15, 2022 CHANGE OF SUPERVISOR CHANG Declaration of Voting Results & Voting Rights Announcements	2022-08-15	English
DATE OF BOARD MEETING Regulatory Filings	2022-08-11	English
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL PROGRESS OF RECOMBINANT HPV 9-VALENT VACCINE Regulatory Filings	2022-08-09	English
VOLUNTARY ANNOUNCEMENT APPROVAL OF THE COMPARATIVE STUDY BETWEEN ReCOV AND mRNA VACCINES BY FDA IN THE PHILIPPINES Regulatory Filings	2022-08-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 Regulatory Filings	2022-08-01	English
Form of Proxy for use at the 2022 First H Share Class Meeting to be held on Monday, August 15, 2022 Proxy Solicitation & Information Statement	2022-07-28	English
Form of Proxy for use at the 2022 First Extraordinary General Meeting to be held on Monday, August 15, 2022 Proxy Solicitation & Information Statement	2022-07-28	English
NOTICE OF H SHARE CLASS MEETING Proxy Solicitation & Information Statement	2022-07-28	English
NOTICE OF EXTRAORDINARY GENERAL MEETING AGM Information	2022-07-28	English
APPLICATION FOR "FULL CIRCULATION" OF UNLISTED SHARES OF THE COMPANY AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS AND ITS DELEGATED PERSONS TO DEAL WITH MATTERS RELATED TO THE APPLICATION Proxy Solicitation & Information Statement	2022-07-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 Regulatory Filings	2022-07-04	English
CHANGE OF JOINT COMPANY SECRETARY AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES Board/Management Information	2022-06-30	English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION PROPOSED CHANGE OF REGISTERED ADDRESS OF THE COMPANY AND PROPOSED CHANGES OF SUPERVISORS Board/Management Information	2022-06-30	English
INSIDE INFORMATION ANNOUNCEMENT PROPOSED PARTICIPATION IN THE H SHARE FULL CIRCULATION PLAN BY THE COMPANY AND CLOSURE OF REGISTER OF MEMBERS Capital/Financing Update	2022-06-30	English
VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL APPROVAL FOR mRNA COVID-19 VACCINE FOR OMICRON VARIANT IN THE PHILIPPINES Regulatory Filings	2022-06-27	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 17, 2022 AND CHANGE OF SUPERVISOR Declaration of Voting Results & Voting Rights Announcements	2022-06-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 Regulatory Filings	2022-06-01	English
2021 Environmental, Social and Governance Report Environmental & Social Information	2022-05-31	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2022-05-26	English
Form of Proxy for use at the 2021 Annual General Meeting to be held on Friday, June 17, 2022 AGM Information	2022-05-18	English
NOTICE OF 2021 ANNUAL GENERAL MEETING AGM Information	2022-05-18	English
(1) 2021 FINANCIAL ACCOUNTS REPORT (2) 2022 FINANCIAL BUDGET REPORT (3) 2021 WORK REPORT OF THE BOARD OF DIRECTORS (4) 2021 WORK REPORT OF THE SUPERVISORY BOARD (5) 2021 ANNUAL REPORT (6) ENGAGEMENT O AGM Information	2022-05-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 Regulatory Filings	2022-05-06	English
CLOSURE OF REGISTER OF MEMBERS AGM Information	2022-05-03	English
VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL APPROVAL FOR RECOV IN THE PRC AND THE OVERSEAS CLINICAL TRIAL PROGRESS OF RECOV Regulatory Filings	2022-05-02	English
2021 Annual Report Annual Report	2022-04-27	English
Next Day Disclosure Return Share Issue/Capital Change	2022-04-27	English
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Capital/Financing Update	2022-04-24	English
PROPOSED CHANGE OF A SUPERVISOR Board/Management Information	2022-04-20	English
VOLUNTARY ANNOUNCEMENT RECEIPT OF APPROVAL FROM THE UAE FOR PHASE II/III CLINICAL TRIAL OF SEQUENTIAL BOOSTER VACCINATION FOR RECOV Regulatory Filings	2022-04-13	English
VOLUNTARY ANNOUNCEMENT SUCCESSFUL PASSING OF THE EU QUALIFIED PERSON AUDIT OF THE GROUP'S MANUFACTURING FACILITY FOR RECOV IN TAIZHOU, THE PRC Regulatory Filings	2022-04-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 Regulatory Filings	2022-04-04	English
FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021 Regulatory Filings	2022-03-31	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-03-30	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD Governance Information	2022-03-30	English
TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD Remuneration Information	2022-03-30	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD Governance Information	2022-03-30	English
ARTICLES OF ASSOCIATION Governance Information	2022-03-30	English
ANNOUNCEMENT OF ALLOTMENT RESULTS Regulatory Filings	2022-03-30	English
Documents on Display Regulatory Filings	2022-03-20	English
GREEN APPLICATION FORM Capital/Financing Update	2022-03-20	English
GLOBAL OFFERING Regulatory Filings	2022-03-20	English
GLOBAL OFFERING Capital/Financing Update	2022-03-20	English
PHIP (1st submission) Audit Report / Information FY 2021	2022-03-13	English
PHIP (1st submission) Regulatory Filings	2022-03-13	English
Application Proof (1st submission) Regulatory Filings	2022-01-21	English
Application Proof (1st submission) Regulatory Filings	2022-01-21	English